Frank J. Accurso

19.6k total citations · 4 hit papers
191 papers, 12.5k citations indexed

About

Frank J. Accurso is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Frank J. Accurso has authored 191 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Pulmonary and Respiratory Medicine, 24 papers in Epidemiology and 23 papers in Physiology. Recurrent topics in Frank J. Accurso's work include Cystic Fibrosis Research Advances (129 papers), Neonatal Respiratory Health Research (98 papers) and Tracheal and airway disorders (46 papers). Frank J. Accurso is often cited by papers focused on Cystic Fibrosis Research Advances (129 papers), Neonatal Respiratory Health Research (98 papers) and Tracheal and airway disorders (46 papers). Frank J. Accurso collaborates with scholars based in United States, Canada and United Kingdom. Frank J. Accurso's co-authors include Jeffrey S. Wagener, Steven H. Abman, Marci K. Sontag, Scott D. Sagel, David W. H. Riches, José Antônio Baddini Martínez, Bruce C. Marshall, Philip M. Farrell, Preston W. Campbell and Terry B. White and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Frank J. Accurso

189 papers receiving 12.2k citations

Hit Papers

Early Pulmonary Inflammation in Infants with Cystic Fibrosis 1995 2026 2005 2015 1995 2008 2003 2017 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank J. Accurso United States 57 9.9k 2.0k 1.8k 1.3k 1.0k 191 12.5k
Michael W. Konstan United States 71 15.2k 1.5× 2.5k 1.3× 2.2k 1.2× 2.2k 1.7× 743 0.7× 243 18.0k
Isabelle Sermet‐Gaudelus France 49 6.8k 0.7× 1.6k 0.8× 1.9k 1.0× 897 0.7× 652 0.6× 259 10.1k
Mary Corey Canada 57 8.7k 0.9× 1.1k 0.6× 1.5k 0.9× 1.1k 0.8× 1.8k 1.7× 156 11.7k
Jane C. Davies United Kingdom 49 9.0k 0.9× 2.8k 1.4× 1.4k 0.8× 1.7k 1.3× 691 0.7× 353 12.8k
Félix Ratjen Canada 65 14.9k 1.5× 2.5k 1.2× 2.2k 1.3× 2.8k 2.1× 1.3k 1.3× 452 18.1k
Eitan Kerem Israel 50 7.1k 0.7× 1.8k 0.9× 1.4k 0.8× 1.1k 0.8× 1.2k 1.2× 263 10.0k
K. De Boeck Belgium 49 7.0k 0.7× 1.4k 0.7× 1.0k 0.6× 1.2k 0.9× 755 0.7× 250 8.9k
James R. Yankaskas United States 53 6.7k 0.7× 3.5k 1.8× 1.1k 0.6× 965 0.7× 1.1k 1.1× 103 10.8k
Matthias Griese Germany 49 8.2k 0.8× 2.2k 1.1× 1.1k 0.6× 1.5k 1.2× 1.9k 1.8× 332 11.7k
Elizabeth Tullis Canada 45 6.4k 0.6× 1.1k 0.6× 777 0.4× 649 0.5× 995 1.0× 158 8.0k

Countries citing papers authored by Frank J. Accurso

Since Specialization
Citations

This map shows the geographic impact of Frank J. Accurso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank J. Accurso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank J. Accurso more than expected).

Fields of papers citing papers by Frank J. Accurso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank J. Accurso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank J. Accurso. The network helps show where Frank J. Accurso may publish in the future.

Co-authorship network of co-authors of Frank J. Accurso

This figure shows the co-authorship network connecting the top 25 collaborators of Frank J. Accurso. A scholar is included among the top collaborators of Frank J. Accurso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank J. Accurso. Frank J. Accurso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mayer-Hamblett, Nicole, George Retsch‐Bogart, Margaret Kloster, et al.. (2018). Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial. American Journal of Respiratory and Critical Care Medicine. 198(9). 1177–1187. 73 indexed citations
2.
Farrell, Philip M., Terry B. White, Clement L. Ren, et al.. (2017). Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. Publisher. 3 indexed citations
3.
Miller, Melissa, David Soave, Weili Li, et al.. (2015). Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic Fibrosis. The Journal of Pediatrics. 166(5). 1152–1157.e6. 35 indexed citations
4.
Raju, S. Vamsee, Patricia L. Jackson, Clifford Courville, et al.. (2013). Cigarette Smoke Induces Systemic Defects in Cystic Fibrosis Transmembrane Conductance Regulator Function. American Journal of Respiratory and Critical Care Medicine. 188(11). 1321–1330. 147 indexed citations
5.
Ramsey, Bonnie W., Susan Banks‐Schlegel, Frank J. Accurso, et al.. (2012). Future Directions in Early Cystic Fibrosis Lung Disease Research: An NHLBI Workshop Report. American Journal of Respiratory and Critical Care Medicine. 185(8). 887–892. 52 indexed citations
6.
Accurso, Frank J., Richard B. Moss, Robert W. Wilmott, et al.. (2010). Denufosol Tetrasodium in Patients with Cystic Fibrosis and Normal to Mildly Impaired Lung Function. American Journal of Respiratory and Critical Care Medicine. 183(5). 627–634. 63 indexed citations
7.
Nick, Jerry A., Robert L. Young, David P. Nichols, et al.. (2010). Effects of Gender and Age at Diagnosis on Disease Progression in Long-term Survivors of Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 182(5). 614–626. 86 indexed citations
8.
Accurso, Frank J., et al.. (2010). Potential of denufosol as an early intervention in CF lung disease: efficacy in patients with minimal pharmacotherapy in a US phase 3 clinical trial. Journal of Cystic Fibrosis. 9. S21–S21. 2 indexed citations
9.
Saavedra, Milene T., Grant Hughes, Linda Sanders, et al.. (2008). Circulating RNA Transcripts Identify Therapeutic Response in Cystic Fibrosis Lung Disease. American Journal of Respiratory and Critical Care Medicine. 178(9). 929–938. 15 indexed citations
10.
Accurso, Frank J.. (2008). Update in Cystic Fibrosis 2007. American Journal of Respiratory and Critical Care Medicine. 177(10). 1058–1061. 26 indexed citations
11.
Accurso, Frank J.. (2007). Update in Cystic Fibrosis 2006. American Journal of Respiratory and Critical Care Medicine. 175(8). 754–757. 29 indexed citations
12.
Mayer-Hamblett, Nicole, Moira L. Aitken, Frank J. Accurso, et al.. (2007). Association between Pulmonary Function and Sputum Biomarkers in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 175(8). 822–828. 188 indexed citations
13.
Papas, Konstantinos, Marci K. Sontag, Ronald J. Sokol, et al.. (2007). A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis. Journal of Cystic Fibrosis. 7(1). 60–67. 23 indexed citations
14.
Sontag, Marci K., Keith Hammond, Julian Zielenski, Jeffrey S. Wagener, & Frank J. Accurso. (2005). Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes. The Journal of Pediatrics. 147(3). S83–S88. 64 indexed citations
15.
Bush, Andrew, Frank J. Accurso, William MacNee, Stephen C. Lazarus, & Edward Abraham. (2005). Cystic Fibrosis, Pediatrics, Control of Breathing, Pulmonary Physiology and Anatomy, and Surfactant Biology in AJRCCM in 2004. American Journal of Respiratory and Critical Care Medicine. 171(6). 545–553. 1 indexed citations
16.
Rodman, David M., Sonya L. Heltshe, Marci K. Sontag, et al.. (2005). Late Diagnosis Defines a Unique Population of Long-term Survivors of Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 171(6). 621–626. 119 indexed citations
17.
Ordoñez, Claudia L., Noreen Henig, Nicole Mayer-Hamblett, et al.. (2003). Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 168(12). 1471–1475. 144 indexed citations
18.
Vandivier, R. William, Valerie A. Fadok, Peter R. Hoffmann, et al.. (2002). Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. Journal of Clinical Investigation. 109(5). 661–670. 271 indexed citations
19.
Vandivier, R. William, Valerie A. Fadok, Peter R. Hoffmann, et al.. (2002). Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. Journal of Clinical Investigation. 109(5). 661–670. 34 indexed citations
20.
Sagel, Scott D., et al.. (2001). Airway Inflammation in Children with Cystic Fibrosis and Healthy Children Assessed by Sputum Induction. American Journal of Respiratory and Critical Care Medicine. 164(8). 1425–1431. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026